Inventor
Yingzi XU
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds45%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
A61KPreparations for medical, dental or toiletry purposes18%
PatentTitleYear
12,528,791Thyroid hormone receptor beta agonist compounds202612,454,524(r)-n-(4-(chlorodifluoromethoxy)phenyl)-2-(difluoromethyl)-1-(1-hydroxypropan-2-yl)-7-(pyrimidin-5-yl)-1H-benzo[d]imidazole-5-carboxamide, or a pharmaceutically acceptable salt or tautomer thereof, for treating certain leukemias202512,398,127Thyroid hormone receptor beta agonist compounds202512,240,835Substituted benzamides as intermediates in the synthesis of inhibitors of tyrosine kinase enzymatic activity202511,203,587Thyroid hormone receptor beta agonist compounds2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021Patents assigned to TERNS INC (1)· patent assignee history
2021–2026Based in US· patent location history
2025–2026Patents assigned to TERNS PHARMACEUTICALS INC (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TERNS PHARMACEUTICALS INC | 4 | 2025–2026 |
| TERNS INC | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2021–2026 |